尼古丁胺衍生物作为DNA脱甲基酶ALKBH2抑制剂的发现和结构-活性关系研究
Ke Xu1, Feng Li2, Liang Xiong2
1Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, 610041, China.
研究人员开发了AH2-14c,这是第一个针对AlkB同源2 (ALKBH2) DNA脱甲基酶的强效和选择性抑制剂. 这种化合物对质母细胞瘤治疗和进一步研究ALKBH2具有前景.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 阿尔克B同源2 (ALKBH2) 是一种Fe (II) 和2氧格酸盐 (2OG) 依赖的DNA脱甲基酶.
- ALKBH2在质母细胞瘤 (GBM) 等癌症中高度表达,影响疾病进展.
- 缺乏用于治疗或研究的强效和选择性ALKBH2抑制剂.
研究的目的:
- 发现和描述ALKBH2.2的新型强效和选择性抑制剂.
- 评估这些抑制剂作为治疗质母细胞瘤的治疗剂的潜力.
- 探索ALKBH2抑制在癌细胞中的作用机制.
主要方法:
- 小分子抑制剂的合成和选.
- 光极化 (FP) 试验以确定IC50值和选择性.
- 细胞测试以评估GBM U87细胞中的抗活力,抗增殖和抗迁移效应.
主要成果:
- 确定AH2-15c是一种强大的ALKBH2抑制剂 (IC50 = 0.031μM),具有>200倍的选择性.
- 细胞透衍生物AH2-14c在增加GBM U87细胞中的DNA 3meC修饰方面表现出卓越的疗效.
- AH2-14c在U87细胞中表现出显著的抗活力,抗扩散和抗迁移活动.
结论:
- AH2-14c是第一个具有证明细胞活性的强效和选择性ALKBH2抑制剂.
- 这种抑制剂有可能成为开发新的质母细胞瘤治疗方法的基础.
- 进一步的研究可以利用AH2-14c来研究ALKBH2在癌症生物学中的作用.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
相关概念视频
Nucleic Acid Structure
DNA Structure
DNA...
The DNA Helix
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Biosynthesis of Nucleic Acids
